Market Scenario:

Cancer is a diverse disease that can originate in different organs and tissues, with each type being associated with different risk factors. Cancer biomarkers are molecules released during the presence of a tumor or a particular indication of cancer in the body. These can either be substance, molecule or a physical event that indicates the existence of cancerous cells in the body. These molecules are generally found in tissues, urine, serum, blood, and other body fluids that indicate any abnormal process or a disease.

The cancer biomarker market is primarily driven by factors including adoption of western lifestyles in the developing regions, extensive research of cancer biomarkers, encouragement for biomarker development by FDA, improved precision and speed of diagnosis, high investment through government and private funds in cancer-related research, and development of highly specific drugs. The global population has witnessed an alarming surge in cancer, with about 14 million new cancer cases reported each year. According to WHO, it is anticipated to further increase over the next two decades by 70% with 22 million new cancer cases in 2012.

Get Exclusive Sample Report @ https://www.marketresearchfuture.com/sample_request/5378 .

Global Market for Digital Pathology – Competitive Landscape

Mikroscan Technologies, Inc., microDimensions GmbH, Omnyx, LLC, Philips Healthcare, ViewsIQ Inc., Apollo Enterprise Imaging Corp., Definiens, Q2 Solutions, GE Healthcare, Huron Digital Pathology Inc, 3DHISTECH Ltd, and Xifin, Inc. are some of the top companies mentioned MRFR’s report

The market is expected grow with the same trends during the forecast period. The major drivers will be rapid technological advancements in digital pathology system such as advancements in digital imaging, robotic light microscopy, and multiple fiber optic communications among others. Moreover, growing prevalence of chronic conditions, that has expected to uplift the demand for digital pathology in order to improve existing patient diagnostic imaging measures and reduce high cost associated with the traditional diagnostics methods. For instance, as per National Pathology Programme, nearly 800 million tests are being performed annually which is equal to 14 for each person in England and Wales. Additionally, increasing R&D applications of static and dynamic systems is fostering the market growth of digital pathology market.

Global Digital Pathology Market - Competitive Analysis:

The market for digital pathology is characterised by the presence of several well-established and small players, the global market of digital pathology appears to be highly competitive and fragmented. Global players are increasingly expanding their footprint in the emerging nations, making it putting pressure on the regional players, especially in terms of features such as type, product portfolios, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. Well established players are entering into mergers & acquisitions, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position. 

Companies like Leica Biosystems; Hamamatsu Photonics, Inc.; and Olympus Corporation are increasingly adopting extensive collaborative strategies to gain more profits and capturing new markets. For instance, in March 2017, Leica Biosystems entered into a strategic partnership with Leeds Hospital to improve productivity and workflow.

Key participants like Royal Philips has acquired the Irish PathXL, one of the largest pathology, image-based analysis firms in order to develop integrated tools targeting applications in computational biology, workflow solutions, education, and image analytics. In addition, these key activities the companies are aiming towards supporting the gradual transition of medical institutions present across the globe from the conventional pathology systems to digital pathology systems.

Thus, we can say that these competitive developments will further enable pathologists to perform high-throughput analysis of clinical image datasets that are diverse in nature and expedite improvement in the diagnosis quality, thereby presenting a potential for adoption new ad improved therapies to enhance patient health outcomes.

Top 10+ Players Business Overview:

microDimensions GmbH (Germany), Mikroscan Technologies, Inc. (U.S.), Q2 Solutions (U.S.), Omnyx, LLC (U.S.), GE Healthcare (UK), Philips Healthcare (U.S.), Huron Digital Pathology Inc. (Canada), ViewsIQ Inc. (Canada), 3DHISTECH Ltd (Hungary) Apollo Enterprise Imaging Corp. (U.S.), Xifin Inc. (U.S.), Definiens (Germany) and others. are some of the prominent players at the forefront of competition in the Global Digital Pathology Market and are profiled in MRFR Analysis.

Major Segmentation:

Digital Pathology Market has been segmented on the basis of types which comprises of human pathology and animal pathology. On the basis of products, market is segmented into scanners, storage server systems, software and others. On the basis of application, market is segmented into mHealth, telemedicine, disease diagnosis, drug discovery and others. On the basis of end user, market is segmented into pharmaceutical companies, hospital/clinics, reference laboratories, research institutes and others.

Get Your Customized Report @ https://www.marketresearchfuture.com/reports/cancer-biomarker-market-5378 .

Table of Content:

1  REPORT PROLOGUE

2  MARKET INTRODUCTION

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3  RESEARCH METHODOLOGY

4  MARKET DYNAMICS

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5  MARKET FACTOR ANALYSIS

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

TOC Continued…!

Get Discount @

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com